logo-loader
NASDAQ:MRKR

Marker Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$99.11 m
Price
2.13 USD
Change
2.90%
52 weeks high
6.54
52 weeks low
1.33

In brief

Marker Therapeutics Inc is a clinical-stage immuno-oncology company with the potential to significantly disrupt the current cell therapy landscape. The company is developing a portfolio of non-genetically modified, multi-antigen T cell therapies, which are able to recognize and kill heterogeneous tumors more effectively than conventional single-antigen CAR-T/TCR approaches.